Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rosenergoatom is the Russian state-owned operator of nuclear power plants and a key subsidiary of the Rosatom State Atomic Energy Corporation. While its primary business is electricity generation, the company is a critical player in the global healthcare sector as one of the world's largest producers of medical isotopes. It utilizes its fleet of nuclear reactors to produce essential radioisotopes such as Molybdenum-99, Iodine-131, Samarium-153, and Cobalt-60, which are fundamental to nuclear medicine for cancer diagnosis, therapy, and the sterilization of medical devices. The company operates specialized irradiation facilities that support the global supply chain for radiopharmaceuticals and medical imaging technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rosenergoatom.